Programme and Operations Manager
Stuart's current role is co-leading a variety of work streams in a large EU-funded private public partnership on adaptive pathways. It aims to successfully explore and develop new conceptual frameworks to expedite patient access to transformative medicines at the European level. In addition Stuart is responsible for developing new collaborative projects and grant opportunities to further CASMI's visibility, agenda and policy impact. Stuart's 15-year career in science has spanned a degree in Biosciences, a PhD in neuroscience, translational models of neonatal brain injury, early phase clinical trials and developing medical devices. A four-year move to Canada saw further research into stem cell treatments for cerebral palsy, coordinating a number of large observational studies in osteoarthritis, and developing new models of healthcare. Stuart has extensive experience of multi-stakeholder projects, grant applications and publications.
Pricing and reimbursement experiences and insights in the European Union and the United States: Lessons learned to approach adaptive payer pathways.
Faulkner SD. et al, (2016), Clin Pharmacol Ther, 100, 730 - 742
An assessment of implications of adaptive licensing for pharmaceutical intellectual property and regulatory exclusivity rights in the European Union.
Meier A. et al, (2016), Clin Pharmacol Ther, 100, 743 - 753